Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.0007 (-10.45%)
At close: May 5, 2026
Evofem Biosciences Employees
Evofem Biosciences had 29 employees as of December 31, 2025. The number of employees decreased by 3 or -9.38% compared to the previous year.
Employees
29
Change (1Y)
-3
Growth (1Y)
-9.38%
Revenue / Employee
$695,966
Profits / Employee
$9,448
Market Cap
795.18K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | -3 | -9.38% | 29 | 0 |
| Dec 31, 2024 | 32 | -6 | -15.79% | 32 | 0 |
| Dec 31, 2023 | 38 | 1 | 2.70% | 37 | 1 |
| Dec 31, 2022 | 37 | -82 | -68.91% | 35 | 2 |
| Dec 31, 2021 | 119 | -28 | -19.05% | 119 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 506 |
| Emmaus Life Sciences | 33 |
| Windtree Therapeutics | 14 |
| Eloxx Pharmaceuticals | 10 |
| CERo Therapeutics Holdings | 8 |
| Abpro Holdings | 3 |
Evofem Biosciences News
- 8 days ago - Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa - Business Wire
- 7 weeks ago - Evofem Reports Fifth Consecutive Year of Net Sales Growth - Business Wire
- 3 months ago - Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026 - Business Wire
- 3 months ago - Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store - Business Wire
- 5 months ago - Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PRNewsWire
- 6 months ago - Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PRNewsWire
- 7 months ago - Evofem Announces Voting Results from Special Meeting of Stockholders - PRNewsWire
- 7 months ago - Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PRNewsWire